Loading…
Loading…
NTUS (Natus Medical Incorporated) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
NTUS does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for NTUS and 80,000+ other tickers.
See exactly how NTUS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NTUS and 80,000+ other tickers.
Natus Medical Incorporated is a global provider of advanced medical device solutions, dedicated to the diagnosis and treatment of conditions affecting the central nervous and sensory systems. The company's offerings are utilized for the screening, detection, therapeutic intervention, ongoing monitoring, and tracking of a wide array of prevalent medical issues. Its product portfolio addresses critical areas such as newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disturbances, and neuromuscular diseases. Natus develops sophisticated computerized…
NEW YORK , June 23, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: U.S. Well Services, Inc. (NASDAQ: USWS)'s sale to ProFrac Holding Corp. Under the terms of the merger agreement, USWS shareholders will receive 0.0561 shares of ProFrac Class A common stock for each share of USWS Class A common stock they own. If you are a USWS shareholder, click here to learn more about your rights and options.
Here is how Natus Medical (NTUS) and Option Care (OPCH) have performed compared to their sector so far this year.
NEW YORK , April 26, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: American Campus Communities, Inc. (NYSE: ACC)'s sale to Blackstone related entities for $65.47 per share in cash. If you are an American Campus shareholder, click here to learn more about your rights and options.
Natus Medical Incorporated (NASDAQ: NTUS) shares are up 25% after the medical device solutions provider for screening, diagnosing and treating disorders that affect the brain sensory nervous systems ad neural pathways signed definitive agreement to be bought by ArchiMed affiliate for $1.2 billion. Shareholders to receive 33.5 per share Stockholders will get $33.50 in cash for […] The post Here is why Natus Medical is up 25% appeared first on Invezz.
A suitor wants to take the company private.